首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1652092

关节内粘稠补充疗法的全球市场:市场规模·占有率·趋势，产业分析 (各产品·各最终用途·各地区)，未来预测 (2025年～2034年)

Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region - Market Forecast, 2025-2034

出版日期: 2025年01月01日 | 出版商:

Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

根据 Polaris Market Research 的一项新研究，全球黏液补充市场预计到 2034 年将达到 152.6 亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场的成长进行了分析。

由于膝关节骨性关节炎 (OA) 盛行率不断上升以及对非手术治疗方案的需求不断增加，黏弹性补充剂市场正在经历显着增长。黏弹性补充疗法是将透明质酸注射到膝关节以缓解疼痛、改善活动能力，并被轻度至中度骨关节炎患者广泛接受。全球人口老化、关节健康意识的增强、以及单次注射和交联形式等透明质酸製剂的进步（这些製剂更加方便、有效）使该市场受益。

扩大采用微创替代关节置换手术是推动黏弹性补充市场扩张的主要驱动力之一。欧洲、北美等地区优惠的报销政策以及新兴国家医疗服务可近性的改善进一步推动了市场需求。技术进步和对更有效配方的持续研究正在为现有企业和新进业者创造巨大的市场机会。

黏液补充剂市场有望实现持续的市场成长，领先的公司正在投资创新和策略合作伙伴关係，以满足不断变化的患者需求，并利用新机会加强其作为骨关节炎管理不可或缺的一部分的作用。

市场前景乐观，由于人口老化加剧、可支配收入增加和医疗保健基础设施改善，亚太地区预计将出现强劲增长。然而，课题依然存在，包括定价压力、替代疗法的竞争和监管障碍。

体内补充剂市场：分析概述

基于产品，三种注射剂型预计将在 2024 年占据最大的市场占有率，因为它们在治疗膝关节骨性关节炎方面具有明确的疗效、广泛的可用性以及医疗保健提供者的偏好。

根据最终用途，预计骨科诊所/ASC 部门将在预测期内以最快的速度增长，这归因于患者越来越倾向于在这些环境中提供的专业化、经济高效和微创治疗。

由于亚太地区人口老化严重且膝关节骨性关节炎盛行率不断上升，预计到 2024 年，该地区将占据关节内置换治疗市场的最大占有率。

由于对先进的骨关节炎治疗的需求不断增加，预计欧洲黏弹性补充剂市场将在预测期内实现最快的复合年增长率。

全球领先公司包括 Anika Therapeutics, Inc.、DePuy Synthes、F. Hoffmann-La Roche Ltd.、Ferring Pharmaceuticals BV、Fidia Farmaceutici SpA、LG Life Sciences Ltd.、Lifecore Biomedical、Sanofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Biofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Biofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Biofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Bio。

主要的分析结果
简介
- 关节内粘稠补充疗法市场评估:各地区 (2020～2034年)
北美
- 北美:各产品 (2020～2034年)
- 北美:各最终用途 (2020～2034年)
- 美国
- 加拿大
欧洲
- 欧洲:各产品 (2020～2034年)
- 欧洲:各最终用途 (2020～2034年)
- 英国
- 法国
- 德国
- 义大利
- 西班牙
- 荷兰
- 俄罗斯
- 其他欧洲
亚太地区
- 亚太地区:各产品 (2020～2034年)
- 亚太地区:各最终用途 (2020～2034年)
- 中国
- 印度
- 马来西亚
- 日本
- 印尼
- 韩国
- 澳洲
- 其他亚太地区
中东·非洲
- 中东·非洲:各产品 (2020～2034年)
- 中东·非洲:各最终用途 (2020～2034年)
- 沙乌地阿拉伯
- 阿拉伯联合大公国
- 以色列
- 南非
- 其他中东·非洲
南美
- 南美:各产品 (2020～2034年)
- 南美:各最终用途 (2020～2034年)
- 墨西哥
- 巴西
- 阿根廷
- 其他南美国家

第8章竞争情形

事业扩大·企业收购的分析
- 事业扩大
- 企业收购
联盟/合作/协定/公开

第9章企业简介

Anika Therapeutics, Inc.
DePuy Synthes
F.Hoffmann-La Roche Ltd.
Ferring Pharmaceuticals B.V.
Fidia Farmaceutici S.p.A
LG Life Sciences Ltd.
Lifecore Biomedical
Sanofi
Seikagaku Corp.
Smith & Nephew PLC
Zimmer Biomet

简介目录图表

Product Code: PM1015

The global viscosupplementation market size is expected to reach USD 15.26 billion by 2034, according to a new study by Polaris Market Research. The report "Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product (Three Injection, Five Injection, and Single Injection), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The viscosupplementation market is experiencing significant growth, driven by the rising prevalence of knee osteoarthritis (OA) and increasing demand for non-surgical treatment options. Viscosupplementation, which involves injecting hyaluronic acid into the knee joint to alleviate pain and improve mobility, has gained widespread acceptance among patients with mild to moderate OA. The market is benefitting from an aging global population, growing awareness of joint health, and advancements in hyaluronic acid formulations, such as single-injection and cross-linked variants, which enhance convenience and efficacy.

The increasing adoption of minimally invasive treatments that offer an alternative to joint replacement surgery is one of the key drivers of the viscosupplementation market expansion. Favorable reimbursement policies in regions like Europe and North America, along with improving healthcare access in emerging economies, have further boosted market demand. Technological advancements and ongoing research into more effective formulations present significant market opportunities for both established players and new entrants.

The viscosupplementation market is poised for sustained market growth, with key players investing in innovation and strategic partnerships to address evolving patient needs and capitalize on emerging opportunities, reinforcing its role as a vital component of osteoarthritis management.

The market outlook is positive, with robust growth expected in Asia Pacific, driven by large elderly populations, rising disposable income, and enhanced healthcare infrastructure. However, challenges such as pricing pressure, competition from alternative treatments, and regulatory hurdles remain.

Key Highlights of Viscosupplementation Market Report

In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.

Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.

In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.

The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.

A few global key market players include Anika Therapeutics, Inc.; DePuy Synthes; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuticals B.V.; Fidia Farmaceutici S.p.A, LG Life Sciences Ltd.; Lifecore Biomedical; Sanofi; Seikagaku Corp.; Smith & Nephew PLC; and Zimmer Biomet.

Polaris Market Research has segmented the viscosupplementation market research report on the basis of product, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Three Injection
Five Injection
Single Injection

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Orthopedic Clinics/ASCs
Hospitals

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Vietnam
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Viscosupplementation Market Insights

4.1. Viscosupplementation Market - Market Snapshot
4.2. Viscosupplementation Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Knee Osteoarthritis
  - 4.2.1.2. Growing Aging Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Treatment Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Viscosupplementation Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Viscosupplementation Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
5.3. Three Injection
- 5.3.1. Global Viscosupplementation Market, by Three Injection, by Region, 2020-2034 (USD Billion)
5.4. Five Injection
- 5.4.1. Global Viscosupplementation Market, by Five Injection, by Region, 2020-2034 (USD Billion)
5.5. Single Injection
- 5.5.1. Global Viscosupplementation Market, by Single Injection, by Region, 2020-2034 (USD Billion)

6. Global Viscosupplementation Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
6.3. Orthopedic Clinics/ASCs
- 6.3.1. Global Viscosupplementation Market, by Orthopedic Clinics/ASCs, by Region, 2020-2034 (USD Billion)
6.4. Hospitals
- 6.4.1. Global Viscosupplementation Market, by Hospitals, by Region, 2020-2034 (USD Billion)

7. Global Viscosupplementation Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Viscosupplementation Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Viscosupplementation Market - North America
- 7.3.1. North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Viscosupplementation Market - U.S.
  - 7.3.3.1. U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Viscosupplementation Market - Canada
  - 7.3.4.1. Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.4. Viscosupplementation Market - Europe
- 7.4.1. Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Viscosupplementation Market - UK
  - 7.4.3.1. UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Viscosupplementation Market - France
  - 7.4.4.1. France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Viscosupplementation Market - Germany
  - 7.4.5.1. Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Viscosupplementation Market - Italy
  - 7.4.6.1. Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Viscosupplementation Market - Spain
  - 7.4.7.1. Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Viscosupplementation Market - Netherlands
  - 7.4.8.1. Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Viscosupplementation Market - Russia
  - 7.4.9.1. Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Viscosupplementation Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.5. Viscosupplementation Market - Asia Pacific
- 7.5.1. Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Viscosupplementation Market - China
  - 7.5.3.1. China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Viscosupplementation Market - India
  - 7.5.4.1. India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Viscosupplementation Market - Malaysia
  - 7.5.5.1. Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Viscosupplementation Market - Japan
  - 7.5.6.1. Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Viscosupplementation Market - Indonesia
  - 7.5.7.1. Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Viscosupplementation Market - South Korea
  - 7.5.8.1. South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Viscosupplementation Market - Australia
  - 7.5.9.1. Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Viscosupplementation Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.6. Viscosupplementation Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Viscosupplementation Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Viscosupplementation Market - UAE
  - 7.6.4.1. UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Viscosupplementation Market - Israel
  - 7.6.5.1. Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Viscosupplementation Market - South Africa
  - 7.6.6.1. South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Viscosupplementation Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.7. Viscosupplementation Market - Latin America
- 7.7.1. Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Viscosupplementation Market - Mexico
  - 7.7.3.1. Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Viscosupplementation Market - Brazil
  - 7.7.4.1. Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Viscosupplementation Market - Argentina
  - 7.7.5.1. Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Viscosupplementation Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Anika Therapeutics, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. DePuy Synthes
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. F.Hoffmann-La Roche Ltd.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Ferring Pharmaceuticals B.V.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Fidia Farmaceutici S.p.A
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. LG Life Sciences Ltd.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Lifecore Biomedical
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Sanofi
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Seikagaku Corp.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Smith & Nephew PLC
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Zimmer Biomet
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development

简介目录图表

List of Tables:

Table 1 Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 2 Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 3 North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 4 North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 5 U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 6 U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 7 Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 8 Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 9 Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 10 Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 11 UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 12 UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 13 France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 14 France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 15 Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 16 Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 17 Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 18 Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 19 Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 20 Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 21 Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 22 Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 23 Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 24 Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 25 Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 26 Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 27 Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 28 Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 29 China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 30 China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 31 India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 32 India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 33 Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 34 Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 35 Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 36 Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 37 Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 38 Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 39 South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 40 South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 41 Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 42 Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 43 Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 44 Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 45 Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 46 Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 47 Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 48 Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 49 UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 50 UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 51 Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 52 Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 53 South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 54 South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 55 Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 56 Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 57 Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 58 Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 59 Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 60 Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 61 Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 62 Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 63 Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 64 Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 65 Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 66 Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Viscosupplementation Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product
Figure 7. Global Viscosupplementation Market, by Product, 2024 & 2034 (USD Billion)
Figure 8. Market by End Use
Figure 9. Global Viscosupplementation Market, by End Use, 2024 & 2034 (USD Billion)

02-2729-4219

+886-2-2729-4219

License/价格

关节内粘稠补充疗法的全球市场:市场规模·占有率·趋势，产业分析 (各产品·各最终用途·各地区)，未来预测 (2025年～2034年)

Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region - Market Forecast, 2025-2034